论文部分内容阅读
目的 观察以诺维本为主的联合方案治疗晚期难治性乳腺癌的疗效。方法 应用诺维本为主的联合方案治疗晚期难治性乳腺癌 2 8例。结果 2 8例病人有效率为 5 3 2 % ,毒副反应主要为骨髓抑制。结论 以诺维本为主的联合方案治疗晚期难治性乳腺癌的疗效较好且大多数病人均能耐受。
Objective To observe the efficacy of combined novettin-based regimen in the treatment of advanced refractory breast cancer. Methods The combination of norviben based regimens in the treatment of advanced intractable breast cancer 28 cases. Results The effective rate of 28 patients was 53.2%. The main toxicities were myelosuppression. Conclusions Noroviben-based combination regimen is effective in the treatment of advanced refractory breast cancer and most patients are tolerant.